FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149447287> ?p ?o ?g. }

• W2149447287 endingPage "685" @default.
• W2149447287 startingPage "675" @default.
• W2149447287 abstract "To retrospectively investigate whether parenchymal enhancement in dynamic contrast material-enhanced magnetic resonance (MR) imaging of the contralateral breast in patients with unilateral invasive breast cancer is associated with therapy outcome.After obtaining approval of the institutional review board and patients' written informed consent, 531 women with unilateral invasive breast cancer underwent dynamic contrast-enhanced MR imaging between 2000 and 2008. The contralateral parenchyma was segmented automatically, in which the mean of the top 10% late enhancement was calculated. Cox regression was used to test associations between parenchymal enhancement, patient and tumor characteristics, and overall survival and invasive disease-free survival. Subset analyses were performed and stratified according to immunohistochemical subtypes and type of adjuvant treatment received.Median follow-up was 86 months. Age (P < .001) and immunohistochemical subtype (P = .042) retained significance in multivariate analysis for overall survival. In patients with estrogen receptor-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer (n = 398), age (P < .001), largest diameter on MR images (P = .049), and parenchymal enhancement (P = .011) were significant. In patients who underwent endocrine therapy (n = 174), parenchymal enhancement was the only significant covariate for overall survival and invasive disease-free survival (P < .001).Results suggest that parenchymal enhancement in the contralateral breast of patients with invasive unilateral breast cancer is significantly associated with long-term outcome, particularly in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. Lower value of the mean top 10% enhancement of the parenchyma shows potential as a predictive biomarker for relatively poor outcome in patients who undergo endocrine therapy. These results should, however, be validated in a larger study." @default.
• W2149447287 created "2016-06-24" @default.
• W2149447287 creator A5027472238 @default.
• W2149447287 creator A5029655930 @default.
• W2149447287 creator A5033195086 @default.
• W2149447287 creator A5063757732 @default.
• W2149447287 creator A5068974737 @default.
• W2149447287 date "2015-09-01" @default.
• W2149447287 modified "2023-09-25" @default.
• W2149447287 title "Association between Parenchymal Enhancement of the Contralateral Breast in Dynamic Contrast-enhanced MR Imaging and Outcome of Patients with Unilateral Invasive Breast Cancer" @default.
• W2149447287 cites W1972273468 @default.
• W2149447287 cites W1987268460 @default.
• W2149447287 cites W1993580329 @default.
• W2149447287 cites W1996440595 @default.
• W2149447287 cites W1996624321 @default.
• W2149447287 cites W1999898292 @default.
• W2149447287 cites W2009856088 @default.
• W2149447287 cites W2035808363 @default.
• W2149447287 cites W2044191288 @default.
• W2149447287 cites W2045684235 @default.
• W2149447287 cites W2061036029 @default.
• W2149447287 cites W2068548884 @default.
• W2149447287 cites W2096864872 @default.
• W2149447287 cites W2096882511 @default.
• W2149447287 cites W2105713473 @default.
• W2149447287 cites W2117340355 @default.
• W2149447287 cites W2124815666 @default.
• W2149447287 cites W2136004986 @default.
• W2149447287 cites W2143635798 @default.
• W2149447287 cites W2146078691 @default.
• W2149447287 cites W2147153911 @default.
• W2149447287 cites W2155113878 @default.
• W2149447287 cites W2158218363 @default.
• W2149447287 cites W2159248767 @default.
• W2149447287 cites W2162332643 @default.
• W2149447287 cites W2165250528 @default.
• W2149447287 cites W2166457180 @default.
• W2149447287 cites W2167465004 @default.
• W2149447287 cites W2313869316 @default.
• W2149447287 cites W267005183 @default.
• W2149447287 doi "https://doi.org/10.1148/radiol.15142192" @default.
• W2149447287 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25811614" @default.
• W2149447287 hasPublicationYear "2015" @default.
• W2149447287 type Work @default.
• W2149447287 sameAs 2149447287 @default.
• W2149447287 citedByCount "65" @default.
• W2149447287 countsByYear W21494472872015 @default.
• W2149447287 countsByYear W21494472872016 @default.
• W2149447287 countsByYear W21494472872017 @default.
• W2149447287 countsByYear W21494472872018 @default.
• W2149447287 countsByYear W21494472872019 @default.
• W2149447287 countsByYear W21494472872020 @default.
• W2149447287 countsByYear W21494472872021 @default.
• W2149447287 countsByYear W21494472872022 @default.
• W2149447287 countsByYear W21494472872023 @default.
• W2149447287 crossrefType "journal-article" @default.
• W2149447287 hasAuthorship W2149447287A5027472238 @default.
• W2149447287 hasAuthorship W2149447287A5029655930 @default.
• W2149447287 hasAuthorship W2149447287A5033195086 @default.
• W2149447287 hasAuthorship W2149447287A5063757732 @default.
• W2149447287 hasAuthorship W2149447287A5068974737 @default.
• W2149447287 hasBestOaLocation W21494472871 @default.
• W2149447287 hasConcept C121608353 @default.
• W2149447287 hasConcept C126322002 @default.
• W2149447287 hasConcept C126838900 @default.
• W2149447287 hasConcept C142724271 @default.
• W2149447287 hasConcept C143409427 @default.
• W2149447287 hasConcept C143998085 @default.
• W2149447287 hasConcept C196822366 @default.
• W2149447287 hasConcept C2777111374 @default.
• W2149447287 hasConcept C2780472235 @default.
• W2149447287 hasConcept C50382708 @default.
• W2149447287 hasConcept C530470458 @default.
• W2149447287 hasConcept C71924100 @default.
• W2149447287 hasConcept C84606932 @default.
• W2149447287 hasConceptScore W2149447287C121608353 @default.
• W2149447287 hasConceptScore W2149447287C126322002 @default.
• W2149447287 hasConceptScore W2149447287C126838900 @default.
• W2149447287 hasConceptScore W2149447287C142724271 @default.
• W2149447287 hasConceptScore W2149447287C143409427 @default.
• W2149447287 hasConceptScore W2149447287C143998085 @default.
• W2149447287 hasConceptScore W2149447287C196822366 @default.
• W2149447287 hasConceptScore W2149447287C2777111374 @default.
• W2149447287 hasConceptScore W2149447287C2780472235 @default.
• W2149447287 hasConceptScore W2149447287C50382708 @default.
• W2149447287 hasConceptScore W2149447287C530470458 @default.
• W2149447287 hasConceptScore W2149447287C71924100 @default.
• W2149447287 hasConceptScore W2149447287C84606932 @default.
• W2149447287 hasIssue "3" @default.
• W2149447287 hasLocation W21494472871 @default.
• W2149447287 hasLocation W21494472872 @default.
• W2149447287 hasOpenAccess W2149447287 @default.
• W2149447287 hasPrimaryLocation W21494472871 @default.
• W2149447287 hasRelatedWork W2073575878 @default.
• W2149447287 hasRelatedWork W2224319365 @default.
• W2149447287 hasRelatedWork W2348152691 @default.
• W2149447287 hasRelatedWork W2369039771 @default.
• W2149447287 hasRelatedWork W2415052584 @default.

• next